MK-2870
id:
mk-2870-194-1361491
title:
MK-2870
text:
MK-2870 or SKB264 is an experimental antibody–drug conjugate. The antibody component is directed against "the trophoblast cell-surface antigen 2 (TROP2), which is overexpressed in many types of solid tumors, coupled to moderate cytotoxic belotecan-derivative through a novel linker which was designed to balance the extracellular stability and intracellular rupture". The drug is developed as a partnership between Merck and the Chinese company Kelun.
brand slug:
wiki
category slug:
encyclopedia
description:
Antibody-drug conjugate
original url:
https://en.wikipedia.org/wiki/MK-2870
date created:
date modified:
2024-04-07T14:29:12Z
main entity:
{"identifier":"Q123663187","url":"https://www.wikidata.org/entity/Q123663187"}
image:
fields total:
13
integrity:
14